🧵Santa Fe accueille la conférence mondiale #CovidLong #KeystoneSymposium
August 10, 2025 at 5:25 PM
🧵Santa Fe accueille la conférence mondiale #CovidLong #KeystoneSymposium
Delighted to be able to present my PhD findings of bNAb in gut tissue, alongside the primary RIO trial findings at the Keystone HIV cure symposium in Durban!
#KeystoneSymposium #HIVcure2025
#KeystoneSymposium #HIVcure2025
Dr Ming Lee, RIO trial physician @drmjlee.bsky.social presents the primary findings from RIO and his gut sub-study at the Keystone HIV cure conference in Durban, S. Africa.
#KeystoneSymposium #HIVcure
#KeystoneSymposium #HIVcure
April 10, 2025 at 7:23 AM
Delighted to be able to present my PhD findings of bNAb in gut tissue, alongside the primary RIO trial findings at the Keystone HIV cure symposium in Durban!
#KeystoneSymposium #HIVcure2025
#KeystoneSymposium #HIVcure2025
Honored to be invited as a speaker at the upcoming #KeystoneSymposium on MASH Pathogenesis and Therapeutic Approaches! I’ll be discussing opportunities and challenges in screening for liver disease in type 2 diabetes.
It's a fantastic program—a must-attend for anyone interested in #MASLD!
It's a fantastic program—a must-attend for anyone interested in #MASLD!
November 12, 2024 at 7:53 PM
Honored to be invited as a speaker at the upcoming #KeystoneSymposium on MASH Pathogenesis and Therapeutic Approaches! I’ll be discussing opportunities and challenges in screening for liver disease in type 2 diabetes.
It's a fantastic program—a must-attend for anyone interested in #MASLD!
It's a fantastic program—a must-attend for anyone interested in #MASLD!
Dr Ming Lee, RIO trial physician @drmjlee.bsky.social presents the primary findings from RIO and his gut sub-study at the Keystone HIV cure conference in Durban, S. Africa.
#KeystoneSymposium #HIVcure
#KeystoneSymposium #HIVcure
April 10, 2025 at 6:58 AM
Dr Ming Lee, RIO trial physician @drmjlee.bsky.social presents the primary findings from RIO and his gut sub-study at the Keystone HIV cure conference in Durban, S. Africa.
#KeystoneSymposium #HIVcure
#KeystoneSymposium #HIVcure
People who receive bNAbs respond differently, some experience delayed rebound beyond 20 weeks after one dose, and some do not rebound at all. However some people still experienced early rebound despite being screened for predicted bNAb resistance.
#KeystoneSymposium #HIVcure2025
#KeystoneSymposium #HIVcure2025
April 10, 2025 at 7:09 AM
People who receive bNAbs respond differently, some experience delayed rebound beyond 20 weeks after one dose, and some do not rebound at all. However some people still experienced early rebound despite being screened for predicted bNAb resistance.
#KeystoneSymposium #HIVcure2025
#KeystoneSymposium #HIVcure2025
#Apresj20 #LongCovid #KeystoneSymposium #SantéPublique #Recherche
www.keystonesymposia.org/conferences/...
www.keystonesymposia.org/conferences/...
Long COVID and Other Post-Acute Infection Syndromes | Keystone Symposia
Join us at the Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes, August 2025, in Santa Fe, with field leaders!
www.keystonesymposia.org
August 10, 2025 at 5:10 PM